Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis

@article{Mccarty1994ComparativeEA,
  title={Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis},
  author={J M Mccarty},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  year={1994},
  volume={13},
  pages={846-850}
}
Cefprozil is a new oral cephalosporin with an enhanced in vitro spectrum of activity that includes group A β-hemolytic streptococci (GABHS). Four multicenter randomized clinical trials were conducted to compare the clinical efficacy and safety of cefprozil administered once or twice a day for the treatment of mild to moderate GABHS tonsillitis and pharyngitis. A total of 1597 patients were enrolled in the trials. Patient demographics and severity of infection were similar for all treatment… CONTINUE READING